CN107411062A - Matrimony vine weight reducing ferment - Google Patents
Matrimony vine weight reducing ferment Download PDFInfo
- Publication number
- CN107411062A CN107411062A CN201710347170.0A CN201710347170A CN107411062A CN 107411062 A CN107411062 A CN 107411062A CN 201710347170 A CN201710347170 A CN 201710347170A CN 107411062 A CN107411062 A CN 107411062A
- Authority
- CN
- China
- Prior art keywords
- matrimony vine
- kilograms
- fat
- blood
- weight reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000241838 Lycium barbarum Species 0.000 title claims abstract description 37
- 235000015459 Lycium barbarum Nutrition 0.000 title claims abstract description 34
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 22
- 244000298479 Cichorium intybus Species 0.000 claims abstract description 16
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 16
- 235000007625 naringenin Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 6
- 230000004151 fermentation Effects 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 claims description 13
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 claims description 13
- 229940117954 naringenin Drugs 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 239000000203 mixture Substances 0.000 abstract description 10
- 230000036772 blood pressure Effects 0.000 abstract description 7
- 230000001093 anti-cancer Effects 0.000 abstract description 5
- 230000001151 other effect Effects 0.000 abstract description 5
- 230000009977 dual effect Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 4
- 238000001914 filtration Methods 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 3
- 235000001497 healthy food Nutrition 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 2
- 238000011081 inoculation Methods 0.000 abstract description 2
- 238000005360 mashing Methods 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 238000001291 vacuum drying Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 235000019197 fats Nutrition 0.000 description 24
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 17
- 238000011160 research Methods 0.000 description 15
- 150000002632 lipids Chemical class 0.000 description 14
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 230000002218 hypoglycaemic effect Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 7
- 108090001061 Insulin Proteins 0.000 description 7
- 208000008589 Obesity Diseases 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 235000015468 Lycium chinense Nutrition 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- -1 carrotene Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- 102000019280 Pancreatic lipases Human genes 0.000 description 3
- 108050006759 Pancreatic lipases Proteins 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229940116369 pancreatic lipase Drugs 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 244000276331 Citrus maxima Species 0.000 description 2
- 235000001759 Citrus maxima Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930003949 flavanone Natural products 0.000 description 2
- 235000011981 flavanones Nutrition 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 244000296825 Amygdalus nana Species 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- SWGKAHCIOQPKFW-JTNORFRNSA-N Caftaric acid Chemical compound OC(=O)[C@H](O)[C@H](C(O)=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-JTNORFRNSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000208947 Cynara Species 0.000 description 1
- 235000003198 Cynara Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 244000181025 Rosa gallica Species 0.000 description 1
- 235000000533 Rosa gallica Nutrition 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- SWGKAHCIOQPKFW-GHMZBOCLSA-N caffeoyltartaric acid Natural products OC(=O)[C@H](O)[C@H](C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-GHMZBOCLSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000006193 cichoric acid Nutrition 0.000 description 1
- 229930016920 cichoric acid Natural products 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 229950009125 cynarine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- VJQAFLAZRVKAKM-QQUHWDOBSA-N lactucin Chemical compound O[C@@H]1CC(C)=C2C(=O)C=C(CO)[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 VJQAFLAZRVKAKM-QQUHWDOBSA-N 0.000 description 1
- VJQAFLAZRVKAKM-UHFFFAOYSA-N lactucine Natural products OC1CC(C)=C2C(=O)C=C(CO)C2C2OC(=O)C(=C)C21 VJQAFLAZRVKAKM-UHFFFAOYSA-N 0.000 description 1
- 230000020958 lipid digestion Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000009805 platelet accumulation Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Matrimony vine weight reducing ferment belongs to healthy food or health food, especially a kind of new product formed with Raw material processings such as natural medicine-food dual purpose plant matrimony vine, arithoke fruit, cynarrhodion, witloof, naringenins, the product has weight reducing weight reducing, lowering blood pressure and blood fat, defaecation, anticancer and other effects, the production technique：Cleaning mashing, mix, digest filtering, homogeneous sterilization, inoculation fermentation, vacuum drying, crushing, test package.
Description
First, technical field：The invention belongs to healthy food or health food, especially with natural medicine-food dual purpose plant matrimony vine, ocean
The raw materials such as Ji fruit, cynarrhodion, witloof, naringenin, take healthy food or health food that biotechnology is process
2nd, background technology：The present invention formed with Raw material processings such as matrimony vine, arithoke fruit, cynarrhodion, witloof, naringenins one
Kind of new product, the product have weight reducing weight reducing, lowering blood pressure and blood fat, hypoglycemic, catharsis and toxin expelling, in addition also with beautifying face and moistering lotion,
Anticancer and other effects.There is no like product also in the market, innovation is researched and developed the product and can provided for the crowd to be reduced weight to weight reducing
A kind of new product.The product is thin as weight reducing made of raw material using pure natural medical and edible dual purpose plant and nutriment and bioactive ingredients
Body ferment, purity height, good absorbing, bioactivity are strong, without any side effects, convenient to take, positive effect is adapted to each age group
Weight reducing crowd take.
3rd, the content of the invention：Obesity is a kind of Nutrition and Metabolism synthesis dysfunctional disease and low whole body chronic inflammation.Research hair
Existing, obesity pathogen is considerably complicated, only not obvious heredity, also closely related with diet and motion.Today obesity into
For the serious common public hygienic issues of a society.
The World Health Organization (WHO) thinks, fat to be listed as the great society problem of the world four with AIDS, drug abuse, fierce wine, cures
Educational circles is referred to as human death and leads high cancer, coronary heart disease, diabetes, hypertension, high fat of blood, cardiovascular and cerebrovascular disease all with obesity
It is directly relevant.
With the fast development of China's economy, the continuous improvement of living standards of the people is fat to turn into concern
Epidemic disease.Shown according to the statistical mathematics of the World Health Organization, number that the whole world is overweight has people more than 300,000,000 seriously fertile more more than 1,000,000,000
It is fat, and the fat ratio of developing country is significantly increased.In the battalion that China announces according to the Ministry of Public Health, the Department of Science and Technology and State Statistics Bureau
Support and show with investigation of health conditions result, there is that 200,000,000 people are overweight in the population of China 1,300,000,000, particularly children are overweight increases rapidly.In advance
Fat illness rate will also have growth by a relatively large margin to meter from now on, and obesity can cause serious threat to national health, can also give
Personal and society brings heavy financial burden.
4th, composition of raw materials：20-80 kilograms of matrimony vine, 30-90 kilograms of arithoke fruit, 10-50 kilograms of cynarrhodion, witloof 15-60 thousand
Gram, 10-15 kilograms of naringenin be raw material.
5th, technical scheme：
(1), matrimony vine：(Lyciam barbarnm extraat), matrimony vine is to be grown in Qinghai-Tibet green ecological environment,
Pure natural treasure medical and edible dual purpose plant matrimony vine dry fruit.Matrimony vine is a kind of rare high-end invigorant of precious ecosystem.Matrimony vine
For matrimony vine of solanaceae plant ripening fruits.It is mild-natured, it is sweet.Return liver and kidney channel.The effect of with nourishing liver and kidney, benefiting shrewd head, moistening lung.
For consumption consumptive loss, soreness of waist and knee joint, dizziness and tinnitus, Heat Diabetes, blood deficiency chlorosis, raising eyesight, blurred vision etc..Modern medicine
Research thinks, matrimony vine have strengthen immunity, antifatigue, lowering blood pressure and blood fat, hypoglycemic, protection liver, fat-reducing, anti-aging,
The functions such as anticancer.
Chemical composition：Matrimony vine is a variety of containing polysaccharide, amino acid, glycine betaine, carrotene, vitamin B, vitamin C, nicotinic acid etc.
The trace element such as vitamin and manganese, chromium, zinc, copper, magnesium, calcium, germanium, cobalt.
Pharmacological action：1st, lowering blood-fat and reducing weight：One research finds that edible matrimony vine has significant fat-reducing effect, and research shows
It can be increased weight amplitude reduction 1/5 that matrimony vine is eaten when eating food rich in fat.Give two groups of high fat of experimental mouse feeding within continuous 3 months
Fat food, one group of experimental mouse are drunk water, another group of experimental mouse feeding matrimony vine.Experimental comparison has found, eats high lipid food feeding Chinese holly simultaneously
The experimental mouse of Qi, after 3 months, other experimental mouses of increased weight Amplitude Ratio lack 18%.Why matrimony vine has significant slimming exercise
Effect, it is because matrimony vine contains abundant polysaccharide, adipocyte, macrophage and vascular endothelial cell can be suppressed respectively, thus sends out
Wave the unique effects of reducing blood lipid, anti-obesity, anti-inflammatory and anti-diabetic and realize fat-reducing.
2nd, liver, anti-fatty liver are protected：Wolfberry fruit extract has certain effect to protection liver and anti-fatty liver tool.It is modern
Medical research is found, contains a kind of active ingredient-glycine betaine in matrimony vine, and it is very effective to treatment liver diseases.Experiment shows, sweet tea
Dish alkali has suppression fat to be deposited in liver cell, promotes the effect of liver cell regeneration.In addition, the middle glycine betaine of matrimony vine can prevent liver
Dirty interior excess fat storage, plays the role of anti-fatty liver, it was reported that feed water extract or glycine betaine feed through rat for a long time
To ccl4Caused hepatic lesion has protective effect, can substantially reduce the change of lipid in transaminase and liver, can suppress lipid in liver
Deposition and promotion liver cell are newborn, have significant protective effect to hepatic lipid peroxidation damage.
3rd, reducing blood lipid, preventing and treating artery sclerosis：Wolfberry fruit extract animal and clinical trial are respectively provided with good effect for reducing blood fat.
Polysaccharide has obvious effect to the blood fat of high fat of blood rabbit, can substantially reduce the content of serum cholesterol and triacylglycerol.Matrimony vine
Rat cholesterolemia can be also reduced, and substantially suppresses to feed the rabbit anteserum cholesterol rise of cholesterol and lard, is also had anti-
The effect of artery sclerosis.
4th, hypotensive and protection cardiovascular and cerebrovascular：Gradually oxidation is hardened elastomer in blood vessel, is the master for causing hypertension
Want reason.Matrimony vine can be reduced blood pressure by improving blood vessel elasticity.It is demonstrated experimentally that wolfberry fruit extract can reduce Blood Cholesterol
Level, reduce cholesterol deposition on vascular wall and suppress angiotonase activity to reduce blood pressure.Separately there is research, raised in rat
Wolfberry fruit extract, chromium, zinc composition are added in material, and experimental group blood pressure is significantly lower than control group, its mechanism is wolfberry fruit extract drop
The low formation of free radical, improve the sensitiveness of insulin.
5th, it is anti-oxidant：Matrimony vine has good antioxidation.Matrimony vine can suppress the lipid peroxidation free radical in blood plasma
Nucleus formation, and can block lipid peroxidation.Protection DNA, protein and membrane structure exempt from oxidative damage play it is important
Effect, it is known that the superoxide dismutase activity in human crystalline lens, cornea and vitreum is low, old human plasma and tissue, this
It is that a kind of support mechanism weakens, it may be possible to which the elderly's plasma lipid peroxide content increases.
6th, it is hypoglycemic：Prevent and treat secondary diabetes：Wolfberry fruit extract has significant hypoglycemic and preventing and treating diabetes work(
Energy.Research shows, influence of the LBP-X to the blood glucose and sugar tolerance of normal mouse and causes hyperglycaemia mouse to alloxan
Protective effect show that feed a certain amount of LBP-X to normal mouse respectively, its result makes blood glucose substantially reduce.Sugar tolerance
Experiment shows that a certain amount of LBP-X can substantially resist normal mouse and give blood glucose rise caused by a certain amount of glucose.Grind
Study carefully substantially, LBP-X has hypoglycemic effect to normal and diabetic animal models.Separately it was found that matrimony vine can effectively control meal
Blood glucose afterwards, hence it is evident that reduce Postprandial peak glucose, so as to form the demand of glycemic peaks phase insulin, mitigate insulin cell point
The load of insulin is secreted, so as to have the function that to protect insulin cell.Long-term use can also reduce the effect of fasting blood-glucose.It is real
Test and show, Postprandial peak glucose can be reduced no matter to normal person, or after being taken to sugar tolerance reduction person and is reduced postprandial
Blood sugar level, prevent secondary diabetes.
7th, strengthen immunity：Mouse gavaging water extract or intramuscular injection alcohol extracting thing can significantly increase its reticuloendothelial system
To the phagocytic activity of india ink.Water extract or LBP-X can promote Phagocytosis By The Peritoneal Macrophages In Mice and serum
Middle lysozyme activity.Gavaged to normal or Aged Mice or abdomen LBP-X, peritoneal macrophage c can be significantly increased3B's and Fc
Acceptor number and vigor, Aged Mice suppressor T lymphocyte regulation antibody function can be made to return to the level of adult mice.LBP-X
Sterling has more significant immune response effect than crude product, and every immune indexes (include the immune organ matter of nospecific immunity
Amount, macrophage phagocytosis, the serum hemolysin of specific humoral immunity, in specific cellular immunity to move back hair style abnormal anti-
Should, lymphocyte transformation rate, E red rose pigments etc.) have significant difference.
(2) arithoke fruit (cynara scolymusl), it is the fruit of composite family cynara scolymus category herbaceos perennial.Mild-natured, taste
It is bitter, sweet, Return liver, kidney footpath.With nourishing liver and kidney, strengthening the bones and muscles, wind-damp dispelling, nourishing blood and preventing abortion and other effects.Modern pharmacological research shows, foreign
Ji fruit has fat-reducing, reducing blood lipid, hypotensive, hypoglycemic, diuresis, calmness, protection liver, diastole coronary artery blood vessel, increase pipe arteries and veins blood flow
The effect such as amount, antiviral.
Chemical composition：Containing protein, fat, carbohydrate, flavone compound, cinarine, multivitamin and
Mineral matter and other components.
Pharmacological action：1st, Weight-reducing and lipid-lowering：Research finds that the flavones contained in arithoke fruit can be done directly on adipocyte,
Accelerate lipolysis to burn and produce heat, while fat can also be suppressed and absorbed in enteron aisle, effectively reduce body fat content, prevent
Fat is accumulated in belly, so as to effective control body weight, has antiobesity action.
(3) cynarrhodion, it is the fruit of prunus plant, also known as fructus rosae, has containing abundant multiple nutritional components and subtract
The effect of girth of a garment body.Research finds that the active component that cynarrhodion separately contains can stimulate the metabolism of glucose, has and subtracts well
Girth of a garment body effect.The organic acid that cynarrhodion contains is the intermediate product that body tricarboxylic suppresses circulation, participates in body metabolism and energy
Conversion, to reach the purpose of fat-reducing.This is also the comprehensive function for the various active nutritional ingredient that cynarrhodion contains, and is had significant
Effect of weight reducing.
(4) witloof (chicofy), be herbaceos perennial witloof aerial part, cool in nature, mildly bitter flavor, into.Have
Clearing liver cholagogic, qi-regulating, stomach strengthening and digestion promoting, eliminating the phlegm of promoting the production of body fluid, belly distending pain, poor appetite and other effects.Modern medicine study thinks, witloof
Acted on fat-reducing, hypoglycemic, inducing diuresis to remove edema, reducing blood lipid, defaecation etc..
Chemical composition：Witloof contains aesculetin, lactucin, Cichoric acid, caftaric acid, chlorogenic acid, root tuber
In contain the compositions such as 50% or so synanthrin.
Pharmacological action：1st, lose weight：Witloof contains abundant synanthrin, and synanthrin is soluble dietary fiber, can be absorbed water under one's belt
Expansion forms mucous membrane colloid, makes one to produce satiety and can extend the emptying time of stomach, so as to reduce food intake dose and reduction
Time of the food in small intestine, moreover it is possible to form compound in the material such as small intestine and protein, fat, be unfavorable for the suction of these materials
Receive, so as to reach the purpose of fat-reducing.In addition, synanthrin can also absorb bile acid, the synthesis for reducing cholesterol absorbs, and has reached since institute
Fat-reducing.
2nd, it is hypoglycemic：Research shows, diabetes patient takes after witloof not but not aggravates postprandial hyperglycemia, but also can be with
Improve the glucose tolerance of patient and the sensitiveness to insulin, therefore there is hypoglycemic effect.
3rd, reducing blood lipid：Data shows that witloof can reduce serum total cholesterol and LDL-C, change
Kind blood fat.Its mechanism is because witloof act as synanthrin and can absorb enteral fat, forms fat and is arranged with synanthrin compound with excrement
Go out in vitro, contribute to blood lipid level to reduce.
4th, prevent treating constipation：The synanthrin contained in witloof, intestinal peristalsis can be made, be advantageous to big intestinal contents to colon movement,
Increase defecation frequency, favourable excrement discharge.Synanthrin also has very strong water imbibition simultaneously, increases the water content in stool, thus
Cause stool to soften, thus defecation is become light.
(5) naringenin (Naringenin naningetol), it is the active ingredient of Citrus fruit skin, naringenin is shaddock
The glucoside member of skin glucoside, belongs to flavanone compound, has extensive physiologically active.There are fat-reducing, reducing blood lipid, hypoglycemic, removing certainly
By base, suppress blood platelet accumulations, antiatherosclerosis, prevent and treat hepatopathy, anti-inflammatory, antibacterial, relieving cough and reducing sputum, spasmolysis is sharp
The effect such as antitumor of courage, anticancer.
Chemical composition：Flavanone
Physiological function：1st, weight-reducing：Research shows that pancreatic lipase is the principal digestive enzymes of lipid in water decomposition meals,
By suppressing the activity of pancreatic lipase, reduce or suppress digesting and assimilating for exogenesis lipid, be treatment and improve obesity action machine
One of reason.Research confirms that naringenin has the active function for suppressing pancreatic lipase, can reduce the biological utilisation of energy in food with
And lipid digestion and absorption, there is obvious action to treatment obesity.
2nd, reducing blood lipid：Zoopery confirms, to detecting its Blood Cholesterol, low-density lipoprotein after mouse gavaging naringenin
In vain, the index such as HDL, triglycerides.Test result indicates that naringenin tool be significantly reduced Blood Cholesterol,
Triglycerides and low-density lipoprotein, increasing high density lipoprotein, so as to have the function that reducing blood lipid.
3rd, anti-inflammatory：Rats gavaged naringenin solution is given, can significantly suppress to be implanted into inflammation caused by wool ball, each dosage group
There is antiinflammatory action.Substantially increase with dosage increase antiphlogistic effects.
4th, it is hypoglycemic with treating diabetes：Research shows that naringenin can improve sensitiveness of the human body to insulin, and can protect
The body weight of health is held, there is the effect of preventing and treating diabetes.According to another report, Israel's research finds that naringenin is controlled with mesh first two
The medicine for treating diabetes B has the effect of identical.
In summary, this product has weight-reducing, lowering blood pressure and blood fat, catharsis and toxin expelling, anticancer and other effects.
6th, manufacture craft
1st, cleaning mashing：First the raw material in formula is respectively washed totally, beater is sent into and breaks into pulp.
2nd, mix：After various raw material pulps are mixed, stir.
3rd, enzymolysis filtering：Filtered after mixed pulp is added into 1-5% enzymolysis.
4th, homogeneous is sterilized：Pulp after filtering is heated to 40-80 degree homogeneous, is heated to 5-20 points of 80-120 degree sterilization again
Clock.
5th, inoculation fermentation：By the strain of the pulp addition 1-5% after sterilization, temperature is maintained at 20-30 degree fermentation 30-180
My god.
6th, dry：Pulp after fermentation is sent into low temperature vacuum drier to be dried.
7th, crush：It is 80-120 mesh powder that pulp fermentate, which crushes, after drying.This process obtains fruit ferment semi-finished product.
8th, test package：The fruit ferment inspection of semifinished product is qualified, it is packaged as finished product.
7th, quality standard：
1st, physical and chemical index：
| Matrimony vine ferment | g/100g | 30 |
| Arithoke fruit ferment | g/100g | 20 |
| Cynarrhodion ferment | g/100g | 15 |
| Witloof ferment | g/100g | 30 |
| Naringenin ferment | g/100g | 5 |
2nd, instructions of taking：3 times a day, each 0.5-2.0 grams.
3rd, adaptation population：It is adapted to people to lose weight and the children of all age group.
8th, embodiment：Take 20-80 kilograms of matrimony vine, 30-90 kilograms of arithoke fruit, 10-50 kilograms of cynarrhodion, witloof 15-60 thousand
Gram, 10-15 kilograms of element of shaddock ped be raw material.By above-mentioned raw materials are respectively washed totally, it is sent into beater and makes into pulp, and mix
Conjunction stirs, and is filtered after adding 1-5% enzymolysis, is heated to after 40-80 degree homogeneous and is heated to the sterilization of 80-120 degree
5-20 minutes, the strain temperature for adding 1-5% are maintained at 20-30 degree fermentation 30-180 days, are sent into low temperature vacuum drier vacuum
0.096 kPa of degree, temperature control is dried in vacuo in 30-50 degree, and crushed after being dried is 80-120 mesh powders, is closed through examining
Lattice, it is packaged as finished product.
Claims (1)
- The manufacture craft of ferment 1. matrimony vine is reduced weight, it is characterized in that：20-80 kilograms of matrimony vine, 30-90 kilograms of arithoke fruit, cynarrhodion 10- 50 kilograms, 15-60 kilograms of witloof, 10-15 kilograms of naringenin be raw material, by above-mentioned raw materials are respectively washed totally, feeding is beaten Pulp grinder makes into pulp, and is mixed evenly, and is filtered after adding 1-5% enzymolysis, is heated to after 40-80 degree homogeneous again 80-120 degree sterilization 5-20 minutes are heated to, the strain temperature for adding 1-5% is maintained at 20-30 degree fermentation 30-180 days, is sent into 0.096 kPa of low temperature vacuum drier vacuum, temperature control is dried in vacuo in 30-50 degree, crushed after being dried 80- 120 mesh powders, it is qualified through examining, it is packaged as finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710347170.0A CN107411062A (en) | 2017-05-17 | 2017-05-17 | Matrimony vine weight reducing ferment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710347170.0A CN107411062A (en) | 2017-05-17 | 2017-05-17 | Matrimony vine weight reducing ferment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107411062A true CN107411062A (en) | 2017-12-01 |
Family
ID=60425992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710347170.0A Pending CN107411062A (en) | 2017-05-17 | 2017-05-17 | Matrimony vine weight reducing ferment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107411062A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108142881A (en) * | 2018-03-20 | 2018-06-12 | 爱可道生物科技有限公司 | A kind of arithoke alabastrum extract blood pressure lowering capsule product and its production technology |
| CN109329531A (en) * | 2018-12-21 | 2019-02-15 | 张建荣 | A kind of arithoke tea and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080021418A1 (en) * | 2003-07-29 | 2008-01-24 | Kao Corporation | Lipolysis stimulator |
| CN103931828A (en) * | 2014-02-28 | 2014-07-23 | 万客齐食品（云南）有限公司 | Artichoke tea and preparation method thereof |
| CN104187602A (en) * | 2014-06-30 | 2014-12-10 | 青海圣烽生物技术开发有限公司 | Chinese wolfberry ferment preparation method |
| CN104642078A (en) * | 2013-11-25 | 2015-05-27 | 邵艳艳 | Soilless cultivation technology for sunlight greenhouse chrysanthemum lettuce in Jiaodong region |
| CN105211864A (en) * | 2015-10-28 | 2016-01-06 | 青海尤尼克生物技术有限公司 | A kind of black fruit lyceum mixed fruit ferment and preparation method thereof |
-
2017
- 2017-05-17 CN CN201710347170.0A patent/CN107411062A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080021418A1 (en) * | 2003-07-29 | 2008-01-24 | Kao Corporation | Lipolysis stimulator |
| CN104642078A (en) * | 2013-11-25 | 2015-05-27 | 邵艳艳 | Soilless cultivation technology for sunlight greenhouse chrysanthemum lettuce in Jiaodong region |
| CN103931828A (en) * | 2014-02-28 | 2014-07-23 | 万客齐食品（云南）有限公司 | Artichoke tea and preparation method thereof |
| CN104187602A (en) * | 2014-06-30 | 2014-12-10 | 青海圣烽生物技术开发有限公司 | Chinese wolfberry ferment preparation method |
| CN105211864A (en) * | 2015-10-28 | 2016-01-06 | 青海尤尼克生物技术有限公司 | A kind of black fruit lyceum mixed fruit ferment and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 朱宇: "葡萄柚或有助于治疗糖尿病", 《科技导报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108142881A (en) * | 2018-03-20 | 2018-06-12 | 爱可道生物科技有限公司 | A kind of arithoke alabastrum extract blood pressure lowering capsule product and its production technology |
| CN109329531A (en) * | 2018-12-21 | 2019-02-15 | 张建荣 | A kind of arithoke tea and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101695376B (en) | Health-care food for preventing diabetes | |
| CN100356867C (en) | Black edible fungus health food and its preparation method | |
| CN109123643A (en) | A kind of preparation method of cereal generation meal ball | |
| CN106072527B (en) | A kind of natto composition of toxin-expelling and face nourishing and preparation method thereof | |
| CN102919330B (en) | Pine pollen fiber biscuit | |
| CN106901118B (en) | Solid beverage with auxiliary blood sugar reducing effect and preparation method thereof | |
| CN101238893B (en) | High edible fibre chickpea nutritive powder and preparation and application thereof | |
| CN106107463A (en) | Super Quinoa Antifatigue milk tea processing technology | |
| CN102197837B (en) | Sea buckthorn fiber biscuits | |
| CN109907221A (en) | One kind having antioxidant nutritious various-grain flour and preparation method | |
| CN108991078A (en) | A kind of mulberry leaf food of prevention and control rich people's disease and preparation method thereof | |
| CN102150852B (en) | Toxin-eliminating and skin-beautifying convenience food and preparation method thereof | |
| CN108174951A (en) | A kind of mulberry leaf sealwort tea preparation method of auxiliary hyperglycemic | |
| CN107223846A (en) | A kind of suitable middle-aged and old grain healthcare powder | |
| CN106982885A (en) | A kind of arhat fruit cookie and preparation method thereof | |
| CN101946895A (en) | Functional food taking loach as main material and preparation method thereof | |
| CN107411062A (en) | Matrimony vine weight reducing ferment | |
| CN105707681A (en) | Supermicro black fungus nutrient porridge with blood sugar reducing function and making method thereof | |
| CN105613882A (en) | Black barley hypoglycemic tea (milky tea) | |
| CN107048160A (en) | Fruits and vegetables rice flour produts that a kind of diabetes patient is applicable and preparation method thereof | |
| CN106174286A (en) | Senior gold Chinese-wolfberry nutritive fruit jam | |
| CN107927096A (en) | Biscuit of hypoglycemia generation value that suitable diabetic population is eaten and preparation method thereof | |
| CN109620858A (en) | The integration of drinking and medicinal herbs preparation for preventing and treating diabetes | |
| CN109527575A (en) | A kind of lipid-loweringing is cultivated one's moral character toxin-expelling and face nourishing ferment | |
| CN109876053A (en) | A kind of acne-removing inflammation-diminishing, removing toxic substances of clearing liver prescription and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination |